Miri Halperin Wernli, PhD

Linkedin Team icon

Executive President

Dr. Halperin Wernli is a senior pharmaceutical and biomedical executive with over 30 years of strategic and operational leadership and a deep understanding of clinical psychiatry and of drug and product development in heavily regulated environments.

Dr. Halperin Wernli was appointed Executive President in February 2021 and has served on our Board of Directors since August 2020. Prior to joining MindMed, Dr. Halperin Wernli co-founded Creso Pharma, a cannabis company, and listed the company on the Australian Stock exchange (ASX) in October 2016. She was the Group CEO and Executive Director of the Board until August 2020.

Prior to founding Creso Pharma, Dr. Halperin Wernli worked in clinical psychiatry in Swiss academic hospital settings. She later held various global senior leadership positions in the pharma and biotech industries in Switzerland and in the US (Merck, Sharp and Dohme, Roche and Actelion pharmaceuticals) covering Product Development, R&D, and Strategic Marketing. Her extensive pharmaceutical industry and biomedical research and development experience covers the full spectrum from Preclinical to Clinical Development and Strategy, to Drug Registration and Launch, across several therapeutic areas.

Dr. Halperin Wernli is a skilled clinician in child and adult psychiatry and an experienced Pharmaceutical leader with skills and broad expertise in Drug Development, Regulatory Affairs, Project & Portfolio Management, Development Finance & Controlling, and Corporate Strategy and Governance.

Robert Barrow Portrait

Robert Barrow

Chief Executive Officer and Board Director

Carol Vallone Portrait

Carol Vallone

Chair of the Board of Directors, Chair of Compensation Committee, Member of Audit/Finance Committee

Andreas Krebs Portrait

Andreas Krebs

Vice Chair of the Board of Directors, Chair of Nomination and Governance Committee, Member of Audit/Finance Committee

Brigid Makes Portrait

Brigid Makes

Board Director, Chair of Audit Committee

Roger Crystal, MD Portrait

Roger Crystal, MD

Board Director, Member of Nomination & Governance Committee, Member of Compensation Committee

Suzanne Bruhn, PhD Portrait

Suzanne Bruhn, PhD

Board Director, Member of Nomination & Governance Committee, Member of Compensation Committee

Miri Halperin Wernli, PhD Portrait

Miri Halperin Wernli, PhD

Executive President

Daniel Karlin, MD, MA Portrait

Daniel Karlin, MD, MA

Chief Medical Officer

Schond Greenway, MBA Portrait

Schond Greenway, MBA

Chief Financial Officer

Francois Lilienthal, MD, MBA Portrait

Francois Lilienthal, MD, MBA

Chief Commercial Officer

Carrie Liao, CPA Portrait

Carrie Liao, CPA

Corporate Controller & Principal Accounting Officer

Robert Silva, PhD Portrait

Robert Silva, PhD

VP, Head of Development

Robert Malenka, MD, PhD Portrait

Robert Malenka, MD, PhD

Chairman of the Scientific Advisory Board, Nancy Friend Pritzker Professor in Psychiatry and Behavioral Sciences at Stanford University

Peter Bergethon, MD Portrait

Peter Bergethon, MD

Member, Scientific Advisory Board VP, Head of Quantitative & Clinical Technologies, Biogen, Inc.

Robert Dworkin, PhD Portrait

Robert Dworkin, PhD

Professor of Anesthesiology and Perioperative Medicine, Neurology, and Psychiatry at University of Rochester

Maurizio Fava, MD Portrait

Maurizio Fava, MD

Psychiatrist-in-Chief of the Massachusetts General Hospital (MGH)

Maria Oquendo, MD, PhD Portrait

Maria Oquendo, MD, PhD

Ruth Meltzer Professor and Chairman of Psychiatry at University of Pennsylvania, Psychiatrist-in-Chief at the Hospital of the University of Pennsylvania

Peter Gasser, MD Portrait

Peter Gasser, MD

Clinical Advisor

Bridget Walton, MS Portrait

Bridget Walton, MS

VP, Global Regulatory Affairs

Kim PC Kuypers, PhD Portrait

Kim PC Kuypers, PhD

Scientific Collaborator & Advisor

Matthias Liechti, MD, PhD Portrait

Matthias Liechti, MD, PhD

Scientific Collaborator & Advisor

Peter Mack, PhD Portrait

Peter Mack, PhD

VP, Pharmaceutical Development

Carole Abel, MBA Portrait

Carole Abel, MBA

VP, Programs and Portfolio Office (PPO)